Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

le Maughan, A., Sadigh, K., Angulo-Diaz, V., Mandimika, C., Villanueva, M., Lim, J. K., Ogbuagu, O.
Foilsithe in BMC Infect Dis (2019)

Caught in the Act: In Vivo Development of Macrolide Resistance to Campylobacter jejuni Infection

le Lindow, J. C., Poly, F., Tribble, D. R., Guerry, P., Carmolli, M. P., Baqar, S., Porter, C. K., Pierce, K. K., Darsley, M. J., Sadigh, K. S., Dill, E. A., Kirkpatrick, B. D.
Foilsithe 2010